286 related articles for article (PubMed ID: 11027871)
1. Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation.
Reddick WE; Russell JM; Glass JO; Xiong X; Mulhern RK; Langston JW; Merchant TE; Kun LE; Gajjar A
Magn Reson Imaging; 2000 Sep; 18(7):787-93. PubMed ID: 11027871
[TBL] [Abstract][Full Text] [Related]
2. Vulnerability of white matter to insult during childhood: evidence from patients treated for medulloblastoma.
Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Sharpe MB; Laughlin S; Bartels U; Scantlebury N; Law N; Malkin D; Skocic J; Richard L; Mabbott DJ
J Neurosurg Pediatr; 2016 Jul; 18(1):29-40. PubMed ID: 27015518
[TBL] [Abstract][Full Text] [Related]
3. Multivariate analysis of dissemination relapse of medulloblastoma and estimation of its time parameter for craniospinal irradiation.
Inakoshi H; Kayamori R; Tsuchida E; Sakai K; Shibamoto Y; Wakushima H; Ogawa Y; Kobayashi M; Obara T
Radiat Med; 2003; 21(1):37-45. PubMed ID: 12801142
[TBL] [Abstract][Full Text] [Related]
4. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM
J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268
[TBL] [Abstract][Full Text] [Related]
5. Ovarian function in survivors of childhood medulloblastoma: Impact of reduced dose craniospinal irradiation and high-dose chemotherapy with autologous stem cell rescue.
Balachandar S; Dunkel IJ; Khakoo Y; Wolden S; Allen J; Sklar CA
Pediatr Blood Cancer; 2015 Feb; 62(2):317-321. PubMed ID: 25346052
[TBL] [Abstract][Full Text] [Related]
6. Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy.
Sirachainan N; Nuchprayoon I; Thanarattanakorn P; Pakakasama S; Lusawat A; Visudibhan A; Dhanachai M; Larbcharoensub N; Amornfa J; Shotelersuk K; Katanyuwong K; Tangkaratt S; Hongeng S
J Clin Neurosci; 2011 Apr; 18(4):515-9. PubMed ID: 21310618
[TBL] [Abstract][Full Text] [Related]
7. Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients.
Massimino M; Sunyach MP; Barretta F; Gandola L; Garegnani A; Pecori E; Spreafico F; Bonneville-Levard A; Meyronet D; Mottolese C; Boschetti L; Biassoni V; Schiavello E; Giussani C; Carrabba G; Diletto B; Pallotti F; Stefini R; Ferrari A; Terenziani M; Casanova M; Luksch R; Meazza C; Podda M; Chiaravalli S; Puma N; Bergamaschi L; Morosi C; Calareso G; Giangaspero F; Antonelli M; Buttarelli FR; Frappaz D
J Neurooncol; 2020 Jul; 148(3):619-628. PubMed ID: 32567042
[TBL] [Abstract][Full Text] [Related]
8. Preclinical Modeling of Image-Guided Craniospinal Irradiation for Very-High-Risk Medulloblastoma.
Smith SMC; Bianski BM; Orr BA; Harknett G; Onar-Thomas A; Gilbertson RJ; Merchant TE; Roussel MF; Tinkle CL
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):728-737. PubMed ID: 30366006
[TBL] [Abstract][Full Text] [Related]
9. Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.
Yoon JH; Park KD; Kang HJ; Kim H; Lee JW; Kim SK; Wang KC; Park SH; Kim IH; Shin HY
World J Pediatr; 2017 Aug; 13(4):367-373. PubMed ID: 28550392
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma.
Jakacki RI; Feldman H; Jamison C; Boaz JC; Luerssen TG; Timmerman R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):531-6. PubMed ID: 15380589
[TBL] [Abstract][Full Text] [Related]
11. Late toxicity following craniospinal radiation for early-stage medulloblastoma.
Christopherson KM; Rotondo RL; Bradley JA; Pincus DW; Wynn TT; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Apr; 53(4):471-80. PubMed ID: 24564687
[TBL] [Abstract][Full Text] [Related]
12. Association Between Brain Substructure Dose and Cognitive Outcomes in Children With Medulloblastoma Treated on SJMB03: A Step Toward Substructure-Informed Planning.
Acharya S; Guo Y; Patni T; Li Y; Wang C; Gargone M; Ashford JM; Wilson L; Faught A; Reddick WE; Patay Z; Gajjar A; Conklin HM; Merchant TE
J Clin Oncol; 2022 Jan; 40(1):83-95. PubMed ID: 34714708
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy for children with newly diagnosed medulloblastoma: A report from the Japanese Pediatric Brain Tumor Consortium.
Okada K; Soejima T; Sakamoto H; Hirato J; Hara J
Pediatr Blood Cancer; 2020 Nov; 67(11):e28572. PubMed ID: 32710713
[TBL] [Abstract][Full Text] [Related]
14. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma.
Polkinghorn WR; Dunkel IJ; Souweidane MM; Khakoo Y; Lyden DC; Gilheeney SW; Becher OJ; Budnick AS; Wolden SL
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e15-20. PubMed ID: 21481547
[TBL] [Abstract][Full Text] [Related]
15. Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma.
Howell RM; Giebeler A; Koontz-Raisig W; Mahajan A; Etzel CJ; D'Amelio AM; Homann KL; Newhauser WD
Radiat Oncol; 2012 Jul; 7():116. PubMed ID: 22828073
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of long-term survivors of metastatic medulloblastoma treated with reduced-dose craniospinal irradiation.
Irikura T; Fukuoka K; Nakazawa A; Ichimura K; Kurihara J; Koh K
Childs Nerv Syst; 2023 Sep; 39(9):2505-2507. PubMed ID: 37185696
[TBL] [Abstract][Full Text] [Related]
17. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.
Yock TI; Yeap BY; Ebb DH; Weyman E; Eaton BR; Sherry NA; Jones RM; MacDonald SM; Pulsifer MB; Lavally B; Abrams AN; Huang MS; Marcus KJ; Tarbell NJ
Lancet Oncol; 2016 Mar; 17(3):287-298. PubMed ID: 26830377
[TBL] [Abstract][Full Text] [Related]
18. Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma.
Brown AP; Barney CL; Grosshans DR; McAleer MF; de Groot JF; Puduvalli VK; Tucker SL; Crawford CN; Khan M; Khatua S; Gilbert MR; Brown PD; Mahajan A
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):277-84. PubMed ID: 23433794
[TBL] [Abstract][Full Text] [Related]
19. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: a 5-year follow-up study.
Wahba HA; Abu-Hegazy M; Wasel Y; Ismail EI; Zidan AS
J BUON; 2013; 18(2):425-9. PubMed ID: 23818356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
